Print this page
Highlights – 3
rd
Quarter 2012
Sales grew by 11.8% to € 2,722 million (Q3 2011: € 2,434 million)
Strong organic sales growth driven by exceptional performance from Performance Materials division and continued momentum in Merck Serono division
EBITDA pre one-time items increased by 15.6% to € 754 million (Q3 2011: € 653 million)
Reported earnings lowered by one-time items of € 104 million, including € 45 million from the restructuring program
Strong operational performance and working capital management boosted free cash flow to a record of € 815 million
Sales
EBITDA pre one-time items
€ million
€ million
made by Nexxar - your next annual report online!, Vienna - Austria
